Evidence map›Paper›PMID 28746373›Full record

ArticlePLoS pathogens2017

Zika virus preferentially replicates in the female reproductive tract after vaginal inoculation of rhesus macaques.

Timothy Carroll, Ming Lo, Marion Lanteri, Joseph Dutra, Katie Zarbock, Paola Silveira, Tracy Rourke, Zhong-Min Ma, Linda Fritts, Shelby O'Connor and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 4 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 4 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Zika virus infection in the genital tract of non-pregnant females: a systematic review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2020
    Pooled it
  3. Guideline
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Timothy CarrollCenter for Comparative Medicine University of California, Davis, Davis, California, United States of America.ORCID http://orcid.org/0000-0002-3459-3364
Ming LoCenter for Comparative Medicine University of California, Davis, Davis, California, United States of America.ORCID http://orcid.org/0000-0002-4280-3560
Marion LanteriBlood Systems Research Institute, San Francisco, California, United States of America.
Joseph DutraCenter for Comparative Medicine University of California, Davis, Davis, California, United States of America.ORCID http://orcid.org/0000-0002-5553-5200
Katie ZarbockWisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, United States of America.
Paola SilveiraFederal University of Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-1743-3876
Tracy RourkeCenter for Comparative Medicine University of California, Davis, Davis, California, United States of America.
Zhong-Min MaCenter for Comparative Medicine University of California, Davis, Davis, California, United States of America.
Linda FrittsCenter for Comparative Medicine University of California, Davis, Davis, California, United States of America.ORCID http://orcid.org/0000-0003-3703-4629
Shelby O'ConnorWisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, United States of America.
Michael BuschBlood Systems Research Institute, San Francisco, California, United States of America.ORCID http://orcid.org/0000-0002-1446-125X
Christopher J MillerCenter for Comparative Medicine University of California, Davis, Davis, California, United States of America.ORCID http://orcid.org/0000-0002-1381-1975
University of California, Davis · USBlood Systems Research Institute · USUniversity of Wisconsin–Madison · USUniversidade Federal do Rio de Janeiro · BR

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
ZONA PELLUCIDA PEPTIDES AS IMMUNOCONTRACEPTIVE ANTIGENSP51RR000169 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI HYDE, DALLAS MELVIN · 1985 to 2011
$126.2M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
A NHP model for vaginal Zika Virus transmissionR21OD023818 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MILLER, CHRISTOPHER JAMES · 2016 to 2016
$312k
NCRR NIH HHS P51 RR000167NCRR NIH HHS P51 RR000169NIH HHS P51 OD011106NIH HHS P51 OD011107NIH HHS R21 OD023818
6 · The paper itself

Abstract

Zika virus (ZIKV) is a mosquito-transmitted virus that can cause severe defects in an infected fetus. ZIKV is also transmitted by sexual contact, although the relative importance of sexual transmission is unclear. To better understand the role of sexual transmission in ZIKV pathogenesis, a nonhuman primate (NHP) model of vaginal transmission was developed. ZIKV was readily transmitted to mature cycling female rhesus macaque (RM) by vaginal inoculation with 104-106 plaque-forming units (PFU). However, there was variability in susceptibility between the individual RM with 1->8 vaginal inoculations required to establish infection. After treatment with Depoprovera, a widely used contraceptive progestin, two RM that initially resisted 8 vaginal ZIKV inoculations became infected after one ZIKV inoculation. Thus, Depoprovera seemed to enhance susceptibility to vaginal ZIKV transmission. Unexpectedly, the kinetics of virus replication and dissemination after intravaginal ZIKV inoculation were markedly different from RM infected with ZIKV by subcutaneous (SQ) virus inoculation. Several groups have reported that after SQ ZIKV inoculation vRNA is rapidly detected in blood plasma with vRNA less common in urine and saliva and only rarely detected in female reproductive tract (FRT) secretions. In contrast, in vaginally inoculated RM, plasma vRNA is delayed for several days and ZIKV replication in, and vRNA shedding from, the FRT was found in all 6 animals. Further, after intravaginal transmission ZIKV RNA shedding from FRT secretions was detected before or simultaneously with plasma vRNA, and persisted for at least as long. Thus, ZIKV replication in the FRT was independent of, and often preceded virus replication in the tissues contributing to plasma vRNA. These results support the conclusion that ZIKV preferentially replicates in the FRT after vaginal transmission, but not after SQ transmission, and raise the possibility that there is enhanced fetal infection and pathology after vaginal ZIKV transmission compared to a mosquito transmitted ZIKV.

Indexed as

AnimalsDisease Models, AnimalFemaleGenitalia, FemaleMacaca mulattaVaginaVirus ReplicationVirus SheddingZika VirusZika Virus Infection

Identifiers

PMID28746373
PMCPMC5546709
OpenAlexW2737407610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.